How To Treat Mesothelioma
|
|
- Trevor McCoy
- 3 years ago
- Views:
Transcription
1 Mesothelioma in the UK Liz Darlison Mesothelioma UK The National Macmillan Mesothelioma Resource Centre June 2010 Mesothelioma Applied Research Foundation
2 Contents Size of Mesothelioma epidemic in UK Why we have so much Mesothelioma What we are doing about asbestos exposure A typical patient journey including treatment and trials in the NHS Sources of Help and Support
3 deaths registered 1864 deaths in UK in deaths in UK in deaths in UK in 2008 (incidence 2327) Mesothelioma Applied Research Foundation
4 Patient Demographics Age Mean Median SD Range Frequency Mesothelioma Applied Research Foundation Age at Diagnosis Asbestos 0 74% reported definite or possible exposure to asbestos Age Source: Alex Chapman, Martin Muers et al, Leeds
5 The problem is not going away! Mesothelioma Applied Research Foundation
6
7
8
9
10 A coalition campaign led by the British Lung Foundation to raise awareness about mesothelioma. Partnership Event Patient, Carers, Charities, Asbestos Support Groups, Industry, Health Care Professionals 2010 Year 5 Coordinated by Mesothelioma UK
11 Investigations Chest Xray Staging CT MRI/PET Pleural aspiration U/S or CT guided biopsy Mesothelioma Applied Research Foundation Thoracoscopy (medical/surgical)
12 Treatment options There are no national guidelines Clinical trials lacking ASC appropriate for all and involves: regular follow-up, nursing support, rapid referral if required, and assessment of, and appropriate treatment for, physical, psychological, and social problems There is a variation in practice
13 Developments Mesothelioma framework Revised BTS Statement on Mesothelioma (in press) Clinical Trials Mesothelioma Applied Research Foundation
14 Not enough body of clinical evidence for Nice guidelines Network leads for MPM Specialist MPM MDT s Education particularly in high incidence areas All MPM patients have a key worker
15 Treatment Options Supportive/specialist palliative care Chemotherapy Radiotherapy Surgery Multi-modality treatment rare Mesothelioma Applied Research Foundation
16
17 Radiotherapy Entire pleural surface - significant response or increased survival not demonstrated Adjuvant in early presentation combined with surgery and chemo. currently under evaluation Prophylactic - drain/aspiration sites Palliative - sites of symptomatic disease
18 The Role of the Thoracic Surgeon in Malignant Mesothelioma Tissue diagnosis Tumour staging Symptom Control Radical Resection Mesothelioma Applied Research Foundation
19 Trials MSO1 Randomised trial of Active symptom control with or without chemotherapy MALCS Research to estimate the mesothelioma and lung cancer risks associated with specific occupations and work practices across Britain Meso/VATS Randomised trial of video-assisted thoracoscopic cytoreductive Pleurectomy vs talc pleurodesis MARS & MARS 2 Does radical surgery (Extra pleural pneumonectomy (EPP)) improve survival?
20 Who do patients/carers turn to? Family and Friends GP Family Health Books Internet Asbestos Support Groups Hospital consultant Lung Cancer Nurses Ward/Clinic Nurses 2,700,000
21 Incidence Vs IIDB Claims Mesothelioma Applied Research Foundation
22 Benefits and compensation Attendance Allowance Vs Disability Living Allowance Industrial Injuries disablement Benefit Lump Sum Payment DS 1500 / BI 100 PN Civil Compensation (Free Prescriptions and Blue Badge)
23 A national nurse led initiative Provide high quality, impartial and up-to-date support and information Develop a national network of trained and experienced nurse specialists. Promote nurse-led research. Work in collaboration with charities, organisations and individuals interested in mesothelioma. Promote the development of mesothelioma support groups.
24
25
26 HELP LINE Free phone Help-line Open Monday Friday Opened 13 th September contacts annually 20% Health Care Professionals 58% Patient/Carer 22% Other 54% dealt with by RN
27 Asbestos Support Groups Mesothelioma Applied Research Foundation Bradford Cheshire Clydebank Clydeside Derbyshire Greater Manchester Merseyside North-East Ridings, Leeds Sheffield Hampshire Tayside Barrow West Midlands
28 Mesothelioma Support Groups Barrow in Furness Hampshire LONDON Guys and St Thomas s East London Mesothelioma Support Royal Marsden Hospital Leeds Newcastle Medway/Swale Leicester Swindon & South West Cambridge Southend Mesothelioma Applied Research Foundation West Hertfordshire. East and North Hertfordshire
29
30 M-NAT Mesothelioma Nurse Action Team Mesothelioma UK Mesothelioma Applied Research Foundation
31 Global shift in asbestos use. 70% of global asbestos production originates in 3 Asian countries 10 million lives may be lost before asbestos is banned world wide. 50% of global asbestos consumption occurs in Asian countries (China, Thailand and Indonesia) 3 biggest global consumers are China, Russia, India Mesothelioma Applied Research Foundation
32 Roger Plowman Mesothelioma Applied Research Foundation
33 Thank you Tel: Mesothelioma Applied Research Foundation Fax:
Asbestos and the diseases it causes
Asbestos and the diseases it causes October 2013 Liz Darlison Mesothelioma UK University Hospitals of Leicester Contents What is asbestos Why is it such an issue in the UK Disease Statistics Asbestos Related
More informationMesothelioma Support Services
Asbestos Support Groups Mesothelioma Support Services Helpline 0800 169 2409 There are a number of Asbestos Support Groups (ASGs) across the UK providing services for people with asbestos related diseases;
More informationWhat is Mesothelioma? Mesothelioma is a cancer of the lining of the lung or the abdomen caused by asbestos.
1 Report for: Health and Wellbeing Scrutiny Commission Meeting Date: 29 th October 2015 Subject: Mesothelioma UK Charitable Trust From: Ghislaine Boyd, Business Development Manager, Mesothelioma UK Charitable
More informationMalignant Mesothelioma
Malignant Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
More informationMalignant Mesothelioma
Malignant mesothelioma is a tumour originating from mesothelial cells. 85 95% of mesotheliomas are caused by asbestos exposure. It occurs much more commonly in the chest (malignant pleural mesothelioma)
More informationAsbestos and your lungs
This information describes what asbestos is and the lung conditions that are caused by exposure to it. It also includes information about what to do if you have been exposed to asbestos, and the benefits
More informationThe East Midlands Mesothelioma Multi-disciplinary Team (MDT) Cancer Services Information for Patients
The East Midlands Mesothelioma Multi-disciplinary Team (MDT) Cancer Services Information for Patients i Introduction The team of health professionals looking after you is known as the multidisciplinary
More informationHow To Contact The Lung Cancer And Mesothelioma Multi-Disciplinary Team
Oxford University Hospitals NHS Trust Oxford Lung Cancer and Mesothelioma Multi- Disciplinary Team (MDT) This information leaflet explains the role of the Multi-Disciplinary Team and Specialist Nursing
More informationMesothelioma. Information for people with Mesothelioma. and their carers. Mesothelioma. 2005 Edition. Compiled by Mavis Robinson MBE, RGN
Information for people with Mesothelioma and their carers Compiled by Mavis Robinson MBE, RGN Mesothelioma 2005 Edition Introduction Mesothelioma This booklet is written in an attempt to give basic information
More informationMesothelioma and Asbestos
CANCER INFORMATION FACTSHEET Mesothelioma and Asbestos The information in this factsheet will help you to understand more about mesothelioma. It is an agreed view on this cancer by medical experts. We
More informationSurgical therapy of. who should be operated
SAMO Interdisciplinary Workshop on Chest Tumors Lucerne, 13th and 14th January 2012 Surgical therapy of mesothelioma, who should be operated Walter Weder MD Professor of Surgery University Hospital Zurich
More informationNational Macmillan Mesothelioma Resource Centre. Bulletin April 2008 MESOTHELIOMA UK UPDATE
Direct Line 0116 256 3739 Fax 0116 250 2810 Email: mesothelioma.uk@uhl-tr.nhs.uk Helpline 0800 169 2409 Website www.mesothelioma.uk.com MESOTHELIOMA UK National Macmillan Mesothelioma Resource Centre Bulletin
More informationClinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines
Clinical cases in Malignant Pleural Mesothelioma: Adherence to the ESMO Clinical Practice Guidelines Wieneke Buikhuisen The Netherlands Cancer Institute Amsterdam The Netherlands Case (1) Male, 56 year
More informationB10/S/a Cancer: Malignant Mesothelioma (Adult)
B10/S/a 2013/14 NHS STANDARD CONTRACT FOR CANCER: MALIGNANT MESOTHELIOMA (ADULT) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No. Service Commissioner Lead Provider Lead Period Date
More informationL Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,
More informationMesothelioma and Asbestos
Cancer information factsheet Mesothelioma and Asbestos The information in this factsheet will help you to understand more about mesothelioma. It is an agreed view on this cancer by medical experts. We
More informationMesoPDT. Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI. Image Assisted Laser Therapy for Oncology
MesoPDT Photodynamic Therapy for malignant pleural mesothelioma ONCO-THAI Image Assisted Laser Therapy for Oncology Unité Inserm ONCO-THAI «Image Assisted Laser Therapy for Oncology» Inserm ONCO-THAI "Image
More informationMesothelioma Making a Claim
Mesothelioma Making a Claim INJURY & NEGLIGENCE SPECIALISTS Injury & Negligence Nothing short of excellent Quote about Pannone part of Slater & Gordon, from Mr G. Essex WELCOME TO PANNONE PART OF SLATER
More informationHow To Treat A Cancer With A Radical
Management of mesothelioma Jan.vanmeerbeeck@ugent.be Amsterdam, March 6, 2010 1 management Palliation Symptomatic care Pain Breathlessness Radiotherapy Chemotherapy Surgery Radical (intention to cure)
More informationSalisbury Lung Cancer Service (1 of 5)
Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.
More informationMalignant Mesothelioma: an Update
Malignant Mesothelioma: an Update Nico van Zandwijk Asbestos Diseases Research Institute Bernie Banton Centre University of Sydney Australia Physicians Week RACP 19-5-2009 Health Risks of Asbestos Fibers
More informationMesothelioma Framework
Gateway Ref: 7907 Mesothelioma Framework Advice for the NHS on how to organise services for Malignant Pleural Mesothelioma (MPM) patients to improve quality of care across the country 27 February 2007
More informationMesothelioma. 1. Introduction. 1.1 General Information and Aetiology
Mesothelioma 1. Introduction 1.1 General Information and Aetiology Mesotheliomas are tumours that arise from the mesothelial cells of the pleura, peritoneum, pericardium or tunica vaginalis [1]. Most are
More informationPATIENT INFORMATION SHEET
PATIENT INFORMATION SHEET Surgical and large bore pleural procedures in Malignant pleural Mesothelioma And Radiotherapy Trial (SMART trial) Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire
More informationMalignant pleural mesothelioma P/D vs. EPP
3 rd International Thoracic Oncology Congress Dresden, September 13 15, 2012 Malignant pleural mesothelioma P/D vs. EPP Walter Weder, MD Professor of Surgery Dokumentenname Datum Seite 1 Extrapleural Pneumonectomy
More informationWhat is mesothelioma?
About this information This information is for people who have been diagnosed with mesothelioma (pronounced mee-zoh-thee-lee-oh-mah ), their friends, families and carers, and for people who want to know
More informationLung Cancer & Mesothelioma 2011-2015
Lung Cancer & Mesothelioma 2011-2015 Annex G Mesothelioma 1. The vision for mesothelioma services is set out in the Mesothelioma Framework issued by DH on 26 February 2007 (supported by the British Thoracic
More informationPlease see the LUCADA data manual v3.1.3, available in the downloads section
National Lung Cancer Audit Frequently Asked Questions What dataset should be used? Please see the LUCADA data manual v3.1.3, available in the downloads section What does LUCADA stand for? LUCADA stands
More informationNational Macmillan Mesothelioma Resource Centre. Bulletin April 2009 MESOTHELIOMA UK UPDATE
Direct Line 0116 256 3739 Fax 0116 250 2810 Email: mesothelioma.uk@uhl-tr.nhs.uk Helpline: 0800 169 2409 Website: www.mesothelioma.uk.com MESOTHELIOMA UK National Macmillan Mesothelioma Resource Centre
More informationMalignant Mesothelioma State of the Art
Malignant Mesothelioma State of the Art Paul Baas The Netherlands Cancer Institute August 12, 2011, Carlsbad, CA Summary Diagnosis; epithelial type subdivided Pleiomorphic vs other Staging: IASLC-IMIG
More informationIs pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
doi:10.1510/icvts.2010.256271 Interactive CardioVascular and Thoracic Surgery 12 (2011) 812 817 www.icvts.org Best evidence topic - Thoracic oncologic Is pleurectomy and decortication superior to palliative
More informationبسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
More informationComplementary Cancer Care Trust Information and Supportive Therapies For People with Life-affecting Illnesses Registered Charity 1083066
Complementary Cancer Care Trust Information and Supportive Therapies For People with Life-affecting Illnesses Registered Charity 1083066 Serves the Borough of Bexley, South East London, And North Kent
More information2015/16 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)-
2015/16 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)- SECTION B PART 1 - SERVICE SPECIFICATION FOR LUNG CANCER Service specification
More informationMESOTHELIOMA UK National Macmillan Mesothelioma Resource Centre
MESOTHELIOMA UK National Macmillan Mesothelioma Resource Centre Welcome to Issue 5 of the Patient & Carer Newsletter. I hope that the information in this newsletter is useful. Best wishes, Liz Darlison
More informationTreating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
More informationPre-workshop exercise
Setting research priorities for mesothelioma workshop 10 th November 2014 Pre-workshop exercise Your individual ranking of unanswered questions about the diagnosis, treatment and care of mesothelioma Please
More informationLife after treatment for Lung Cancer
Oxford University Hospitals NHS Trust Life after treatment for Lung Cancer A guide for patients and their carers Introduction Treatment for Lung Cancer can be very varied depending on the stage and type
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationMesothelioma Priority Setting Partnership. PROTOCOL November 2013
Mesothelioma Priority Setting Partnership PROTOCOL November 2013 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Mesothelioma Priority Setting Partnership
More informationHow treatment is planned Giving your consent The benefits and disadvantages of treatment Second opinion
Treatment overview for lung cancer This information is an extract from the booklet Understanding lung cancer. You may find the full booklet helpful. We can send you a free copy see page 5. Contents How
More informationHow do I find the best place to get treatment for my lymphoma?
Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood
More informationThe epidemiology and treatment of mesothelioma in South East England 1985 2002
The epidemiology and treatment of mesothelioma in South East England 1985 2002 V Mak, E Davies, V Putcha, B Choodari-Oskooei, H Møller King s College London, Thames Cancer Registry, London, UK Correspondence
More informationUniversity College Hospital. The lung cancer multidisciplinary team. Information for patients and carers
University College Hospital The lung cancer multidisciplinary team Information for patients and carers 2 If you would like this document in another language or format, or require the services of an interpreter,
More informationInternational Journal of Case Reports in Medicine
International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon
More informationGIVING INFORMATION TO LUNG CANCER PATIENTS
GIVING INFORMATION TO LUNG CANCER PATIENTS Guidance For Healthcare Professionals Discussing Options For Patients On The Lung Cancer Pathway British Thoracic Society Lung Cancer and Mesothelioma Specialist
More informationMesothelioma: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Mesothelioma: Questions
More informationAsbestos related disease compensation. no-one can change the past, but one of us could change your future
Asbestos related disease compensation no-one can change the past, but one of us could change your future Although asbestos was introduced into the UK in the 19th century, it s only in the last few decades
More informationAsbestos Disease Awareness. help
Asbestos Disease Awareness help Asbestos: Contents Asbestos Disease Awareness Contents What have I got Page 2 The five main types of asbestos How did I get it? Page 3 Can I get compensation? Pages 4/5
More informationAsbestos Brochure. Jim Wyatt - jwyatt@hamers.com Stephen Ball - sball@hamers.com. Freephone: 0800 591 999. www.hamers.com
Jim Wyatt - jwyatt@hamers.com Stephen Ball - sball@hamers.com Freephone: 0800 591 999 5 Earls Court, Priory Park East, Hull, HU4 7DY Tel: 01482 326666 Fax: 01482 324432 Aspect Court, 47 Park Square East,
More informationThe RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial of treatment after surgery for prostate cancer
Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire HP21 8AL Tel: 01296 315 908 www.buckshealthcare.nhs.uk The RADICALS trial Radiotherapy Timing Randomisation (RADICALS-RT) Clinical trial
More informationInformation for Men Diagnosed with Testicular Cancer
Patient Information Service Information for Men Diagnosed with Testicular Cancer Bristol Haematology and Oncology Centre Bristol Testicular Cancer Service Patient Information is supported by September
More informationTreatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians
Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians Background The Cancer Institute New South Wales Oncology Group Lung (NSWOG Lung) identified the need for the development
More informationBreast Cancer. Presentation by Dr Mafunga
Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over
More informationTreatment and recovery: Malignant pleural mesothelioma. Jocelyn Mclean Case Manager for Thoracic Surgery RPAH
Treatment and recovery: Malignant pleural mesothelioma Jocelyn Mclean Case Manager for Thoracic Surgery RPAH This presenta?on Treatment - management op?ons Recovery well living programme Caring for pa?ents,
More informationThe Dream MDT for lung cancer: Delivering high quality lung cancer care and outcomes. UK Lung Cancer Coalition November 2012
The Dream MDT for lung cancer: Delivering high quality lung cancer care and outcomes 1 UK Lung Cancer Coalition November 2012 November 2012 The Dream MDT for lung cancer Contents page Introduction 2 The
More informationInternational Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
More informationSurgery. Wedge resection only part of the lung, not. not a lobe, is removed. Cancer Council NSW
The treatment you receive will depend on your lung cancer type, for example, whether you have a non-small cell lung cancer Adenocarcinoma or Squamous cell carcinoma, and if this is a sub-type with a mutation.
More informationUnderstanding Pleural Mesothelioma
Understanding Pleural Mesothelioma UHN Information for patients and families Read this booklet to learn about: What is pleural mesothelioma? What causes it? What are the symptoms? What tests are done to
More informationHow To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
More informationchemical poisoning. We work in a practical,
Our specialist team has a wealth of experience in dealing with claims arising from asbestos and chemical poisoning. We work in a practical, supportive & clear way, dedicated to gaining the best possible
More informationHamers S O L I C I T O R S. Jim Wyatt jwyatt@hamers.com. Freephone: 0800 591 999. 5 Earls Court, Priory Park, East, Hull HU4 7DY
Hamers S O L I C I T O R S Jim Wyatt jwyatt@hamers.com Freephone: 0800 591 999 5 Earls Court, Priory Park, East, Hull HU4 7DY Tel: 01482 326666 Fax: 01482 324432 www.hamers.com Hamers Solicitors LP is
More informationOncology and haematology clinical trials Information for patients at St Thomas Hospital
Oncology and haematology clinical trials Information for patients at St Thomas Hospital Contents p.2 Contents p.4 Welcome p.4 Meet the team p.6 Where will my appointment be? p.8 Tests and treatments and
More informationMesothelioma. Malignant Pleural Mesothelioma
Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency
More informationCancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
More informationSummary of treatment benefits
Risk Management Plan PEMETREXED Powder for concentrate for Solution for infusion Pemetrexed is also indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non small cell
More informationNational Macmillan Mesothelioma Resource Centre. Bulletin July 2008 MESOTHELIOMA UK UPDATE
Direct Line 0116 256 3739 Fax 0116 250 2810 Email: mesothelioma.uk@uhl-tr.nhs.uk Helpline: 0800 169 2409 Website: www.mesothelioma.uk.com MESOTHELIOMA UK National Macmillan Mesothelioma Resource Centre
More informationPhyllodes tumours: borderline malignant and malignant
Phyllodes tumours: borderline malignant and malignant This booklet is for people who would like more information on borderline malignant or malignant phyllodes tumours. It describes what they are, the
More informationThe role of the Specialist Nurse Practitioner for Late Effects Information for patients
Oxford University Hospitals NHS Trust The role of the Specialist Nurse Practitioner for Late Effects Information for patients This leaflet describes the role of the Specialist Nurse Practitioner for Late
More informationPRIMARY LUNG CANCER TREATMENT
PRIMARY LUNG CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre December 2014 Contents About this booklet 1 Types of Lung Cancer
More informationMesothelioma care guide
Following your diagnosis of mesothelioma, this is a practical, supportive and clear guide on what to do next. Supporting clients with mesothelioma for over twelve years, our Kent-based team has the knowledge
More informationMesothelioma. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com ocft0101 Last reviewed: 03/21/2013 1
Mesothelioma Introduction Mesothelioma is a type of cancer. It starts in the tissue that lines your lungs, stomach, heart, and other organs. This tissue is called mesothelium. Most people who get this
More informationSuccessful International Campaigns on Cancer Prevention: Asbestos Case Study
Successful International Campaigns on Cancer Prevention: Asbestos Case Study by Laurie Kazan-Allen To safeguard the asbestos cash cow, the global asbestos lobby engaged in a high-profile, multilingual
More informationTO BE COMPLETED IF MESOTHELIOMA IS DIAGNOSED OR SUSPECTED NOT TO BE RELEASED WITHOUT PATIENT/NEXT OF KIN S PERMISSION
NOT TO BE RELEASED WITHOUT PATIENT/NEXT OF KIN S PERMISSION MESOTHELIOMA PRO FORMA PART 1 Patient held Record of Information - To be completed by patient/next of kin Demographic Particulars Name:.D.O.B:
More informationMesothelioma UK Conference
DERBYSHIRE ASBESTOS SUPPORT TEAM (DAST) DAST, 34 Glumangate, Telephone 01246 380415 Mesothelioma UK Conference Chesterfield, S40 1TX. Edition. Edited by Joanne Gordon Mesothelioma UK Conference On Saturday
More informationBritish Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015
0116 250 2811 dawn.mckinley@uhl-tr.nhs.uk www.btog.org @BTOGORG British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015 BTOG s Aim BTOG is the multi-disciplinary group for professionals
More informationThe Belgian Asbestos Fund
The Belgian Asbestos Fund Dr. Marc Vandeweerdt Occupational Diseases Fund - Asbestos Fund 22 January 2011 Asbestos: history Asbestos consumption in Europe 1920: 39,276 T 1950: 369,738 T 1975: 1,410,394
More informationNational Centre for Asbestos-Related Diseases
National Centre for Asbestos-Related Diseases A Strategy Document NCARD Development Group November 2009 Contact: Mr John G Edwards PhD FRCS Glasg.(C/Th) Chair, NCARD Development Group Chair, British Mesothelioma
More informationSurgeons Role in Symptom Management. A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND
Surgeons Role in Symptom Management A/Prof Cliff K. C. Choong Consultant Thoracic Surgeon Latrobe Regional Hospital GIPPSLAND Conditions PLEURAL Pleural effusion Pneumothorax ENDOBRONCHIAL Haemoptysis
More informationJohn Pickering and Partners LLP. Mesothelioma. A guide to compensation. Freephone 0800 854201 www.johnpickering.co.uk
John Pickering and Partners LLP Mesothelioma A guide to compensation Freephone 0800 854201 www.johnpickering.co.uk What the Leading Legal Directories say about John Pickering and Partners LLP John Pickering
More informationWhat is hospice care? Answering questions about hospice care
What is hospice care? Answering questions about hospice care Introduction If you, or someone close to you, have a life-limiting or terminal illness, you may have questions about the care you can get and
More informationAsbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease connecting raising awareness supporting advocating 1800 017 758 www.asbestosassociation.com.au Asbestos lagging was widely
More informationAsbestos Related Diseases
Asbestos Related Diseases Asbestosis Mesothelioma Lung Cancer Pleural Disease Asbestosis and Mesothelioma (LUNG CANCER) Support Group 1800 017 758 www.amsg.com.au ii Helping you and your family through
More informationSurvey of Mesothelioma Associated with Asbestos Exposure in Japan
The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics
More informationSpecialists in asbestos litigation
Specialists in asbestos litigation Patient information fact sheet about: Asbestos Compensation Claims Your guide and information pack to explain what financial help is available for those suffering from
More informationInvasive lobular breast cancer
Invasive lobular breast cancer This booklet is about invasive lobular breast cancer. It describes what invasive lobular breast cancer is, the symptoms, how it s diagnosed and possible treatments. Diagnosed
More informationThe National Clinical Lung Cancer Audit (LUCADA)
The National Clinical Lung Cancer Audit (LUCADA) DATA MANUAL Title: Version: 3.1.5 Date: September 2013 LUCADA Lung Cancer Audit VERSION HISTORY Version Date Issued Brief Summary of Change Owner s Name
More informationthe standard of care 2009 5/1/2009 Mesothelioma: The standard of care take home messages PILC 2006 Jan.vanmeerbeeck@ugent.be Brussels, March 7, 2009
Mesothelioma: The standard of care Jan.vanmeerbeeck@ugent.be Brussels, March 7, 2009 take home messages PILC 2006 All patients should receive adequate palliation of dyspnea and pain before starting chemotherapy
More informationAccelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,
More informationSIGN. Scottish Intercollegiate Guidelines Network. for patients. lung cancer
SIGN Scottish Intercollegiate Guidelines Network for patients lung cancer Scottish Intercollegiate Guidelines Network ISBN 978 1 905813 10 0 First published 2007 SIGN consents to the photocopying of this
More informationMalignant pleural mesothelioma: outcome of limited surgical management
Interactive Cardiovascular and Thoracic Surgery 2 (2003) 30 34 Institutional review Thoracic general Malignant pleural mesothelioma: outcome of limited surgical management Peter G. Phillips a, George Asimakopoulos
More informationExtrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012
Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos
More informationRecommendations for cross-sectional imaging in cancer management, Second edition
www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who
More informationMESOTHELIOMA: A GUIDE TO COMPENSATION
MESOTHELIOMA: A GUIDE TO COMPENSATION Contents What is mesothelioma and how is it caused? 4 Welfare benefits and a lump sum payment from the Department for Work and Pensions 5 Personal Independent Payment
More informationThis factsheet aims to outline the characteristics of some rare lung cancers, and highlight where each type of lung cancer may be different.
There are several different kinds of lung cancer, often referred to as lung cancer subtypes. Some of these occur more often than others. In this factsheet we will specifically look at the subtypes of cancers
More informationINJURY & NEGLIGENCE SPECIALISTS Illnesses. Asbestos Illnesses
Asbestos Illnesses INJURY & NEGLIGENCE Asbestos SPECIALISTS Illnesses Injury & Negligence I was totally satisfied with my solicitors service, it was First Class. Quote about Pannone part of Slater & Gordon,
More informationGRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
More information